Wednesday, July 31, 2019

FDA Approves First Nasally Administered Drug for Severe Hypoglycemia

FDA approves a drug for the first time for treating severe hypoglycemia. The drug, BaqsimisupTM/sup, can be administered nasally without an injection, which rapidly elevates blood sugar levels.

from Medindia Latest Updates https://ift.tt/2Yt73HX
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Study finds untreated sleep apnea doubles Parkinson’s risk

A massive veteran study found a strong connection between untreated sleep apnea and a higher chance of Parkinson’s. CPAP users had much lowe...